Borja Del Pozo-Cruz1, Graeme Carrick-Ranson2, Stacey Reading2, Paul Nolan2, Lance C Dalleck3. 1. Department of Exercise Sciences, Faculty of Science, University of Auckland, Building 731 room 340, Tamaki Innovation Campus, 261 Morrin Rd, St Johns, Auckland Private Bag 92019, Auckland, New Zealand. b.delpozocruz@auckland.ac.nz. 2. Department of Exercise Sciences, Faculty of Science, University of Auckland, Building 731 room 340, Tamaki Innovation Campus, 261 Morrin Rd, St Johns, Auckland Private Bag 92019, Auckland, New Zealand. 3. Recreation, Exercise and Sport Science Department, Western State Colorado University, Gunnison, CO, USA.
Abstract
PURPOSE: To quantify the relationship between the change in exercise dose and health-related quality of life (HRQoL) in a cohort of patients participating in a community-based phase-3 cardiac rehabilitation (CR) program. METHODS: A retrospective, pre-experimental (no control group) design of 58 participants that completed a phase-3, 12-week exercise-based CR program was used to test the current hypothesis. Self-reported HRQoL (36-Item Short Form Health Survey Version 2, SF-36v2) was assessed prior and after completing the CR program. The change in exercise dose was estimated from the assigned training load in weeks 1 and 12 of the CR program. A series of regression models were fitted to ascertain the relationship between the change in exercise dose and changes in the SF-36v2. RESULTS: There was a strong quadratic trend between the change in exercise dose and the mean change in SF-36 Mental and Physical Health Summary Scores. Analysis of covariance showed that the mean changes in the SF-36 Summary Scores statistically fluctuate across quartiles of exercise dose. The data show that there is a threshold amount of increase in exercise (Q2; 350-510 kcal week- 1) needed to HRQoL and that greater amounts of exercise dose (Q3; 511-687 and Q4 ≥ 688 kcal week- 1) did not improve HRQoL further. CONCLUSIONS: The current findings suggest that physical and mental health-related quality of life are improved with a phase-3 CR program. The dose-response relationship observed indicates that a threshold exercise dose is required to improve HRQoL, and that larger doses of exercise do not confer further improvements in HRQoL.
PURPOSE: To quantify the relationship between the change in exercise dose and health-related quality of life (HRQoL) in a cohort of patients participating in a community-based phase-3 cardiac rehabilitation (CR) program. METHODS: A retrospective, pre-experimental (no control group) design of 58 participants that completed a phase-3, 12-week exercise-based CR program was used to test the current hypothesis. Self-reported HRQoL (36-Item Short Form Health Survey Version 2, SF-36v2) was assessed prior and after completing the CR program. The change in exercise dose was estimated from the assigned training load in weeks 1 and 12 of the CR program. A series of regression models were fitted to ascertain the relationship between the change in exercise dose and changes in the SF-36v2. RESULTS: There was a strong quadratic trend between the change in exercise dose and the mean change in SF-36 Mental and Physical Health Summary Scores. Analysis of covariance showed that the mean changes in the SF-36 Summary Scores statistically fluctuate across quartiles of exercise dose. The data show that there is a threshold amount of increase in exercise (Q2; 350-510 kcal week- 1) needed to HRQoL and that greater amounts of exercise dose (Q3; 511-687 and Q4 ≥ 688 kcal week- 1) did not improve HRQoL further. CONCLUSIONS: The current findings suggest that physical and mental health-related quality of life are improved with a phase-3 CR program. The dose-response relationship observed indicates that a threshold exercise dose is required to improve HRQoL, and that larger doses of exercise do not confer further improvements in HRQoL.
Entities:
Keywords:
Cardiac rehabilitation; Dose–response; Energy expenditure; Health-related quality of life
Authors: L Vanhees; N Geladas; D Hansen; E Kouidi; J Niebauer; Z Reiner; V Cornelissen; S Adamopoulos; E Prescott; M Börjesson; B Bjarnason-Wehrens; H H Björnstad; A Cohen-Solal; V Conraads; D Corrado; J De Sutter; P Doherty; F Doyle; D Dugmore; Ø Ellingsen; R Fagard; F Giada; S Gielen; A Hager; M Halle; H Heidbüchel; A Jegier; S Mazic; H McGee; K P Mellwig; M Mendes; A Mezzani; N Pattyn; A Pelliccia; M Piepoli; B Rauch; A Schmidt-Trucksäss; T Takken; F van Buuren; D Vanuzzo Journal: Eur J Prev Cardiol Date: 2012-10 Impact factor: 7.804
Authors: Steve E Selig; Itamar Levinger; Andrew D Williams; Neil Smart; David J Holland; Andrew Maiorana; Daniel J Green; David L Hare Journal: J Sci Med Sport Date: 2010-03-15 Impact factor: 4.319
Authors: M Carayol; P Bernard; J Boiché; F Riou; B Mercier; F Cousson-Gélie; A J Romain; C Delpierre; G Ninot Journal: Ann Oncol Date: 2012-10-05 Impact factor: 32.976
Authors: Kym Joanne Price; Brett Ashley Gordon; Stephen Richard Bird; Amanda Clare Benson Journal: Int J Environ Res Public Health Date: 2021-05-28 Impact factor: 3.390